Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients.

Trial Profile

Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Feb 2010

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 02 Mar 2009 Actual patient numbers (25) added as reported by ClinicalTrials.gov.
    • 02 Mar 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
    • 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top